Hennion & Walsh Asset Management, Inc. Exelixis, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

$2.1 Billion
Q4 2024

A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 15,540 shares of EXEL stock, worth $515,151. This represents 0.02% of its overall portfolio holdings.

Number of Shares

15,540

Previous 62,911 75.3%

Holding current value

$515,151

Previous $1.63 Million 68.32%

% of portfolio

0.02%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$25.39 - $36.46 $1.2 Million - $1.73 Million	-47,371 Reduced 75.3%	15,540 $517,000
Q3 2024 Oct 22, 2024	SELL	$21.96 - $27.6 $133,099 - $167,283	-6,061 Reduced 8.79%	62,911 $1.63 Million
Q2 2024 Jul 19, 2024	SELL	$20.34 - $23.73 $13,607 - $15,875	-669 Reduced 0.96%	68,972 $1.55 Million
Q1 2024 Apr 17, 2024	BUY	$20.17 - $23.93 $130,903 - $155,305	6,490 Added 10.28%	69,641 $1.65 Million
Q4 2023 Jan 10, 2024	SELL	$19.25 - $24.13 $17,479 - $21,910	-908 Reduced 1.42%	63,151 $1.51 Million
Q3 2023 Oct 27, 2023	BUY	$19.04 - $22.74 $183,336 - $218,963	9,629 Added 17.69%	64,059 $1.4 Million
Q2 2023 Aug 09, 2023	BUY	$18.17 - $20.48 $84,217 - $94,924	4,635 Added 9.31%	54,430 $1.04 Million
Q1 2023 Apr 20, 2023	BUY	$16.3 - $19.41 $238,517 - $284,026	14,633 Added 41.62%	49,795 $967,000
Q4 2022 Jan 12, 2023	BUY	$14.96 - $17.39 $526,023 - $611,467	35,162 New	35,162 $564,000
Q2 2022 Jul 19, 2022	SELL	$17.44 - $23.16 $1.26 Million - $1.68 Million	-72,473 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$17.03 - $22.67 $62,091 - $82,654	-3,646 Reduced 4.79%	72,473 $1.64 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $1.12 Million - $1.54 Million	-70,392 Reduced 48.05%	76,119 $1.39 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $111,443 - $144,534	-6,837 Reduced 4.46%	146,511 $3.1 Million
Q2 2021 Aug 13, 2021	BUY	$17.95 - $25.56 $59,899 - $85,293	3,337 Added 2.22%	153,348 $2.79 Million
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $3.08 Million - $3.78 Million	150,011 New	150,011 $3.39 Million

Others Institutions Holding EXEL

# of Institutions

520

Shares Held

244M

Call Options Held

2.84M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.

Account

Hennion & Walsh Asset Management, Inc. Exelixis, Inc. Transaction History